PCRX

Pacira BioSciences, Inc.

Healthcare›Drug Manufacturers - Specialty & Generic|NASDAQ Global Select|US

Price

$22.70

Market Cap

$976.58M

Beta

0.23

P/E

156.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+3.63%

EPS Growth (YoY)+106.76%

Revenue CAGR 3Y+2.89%

P/E Ratio156.2

PEG Ratio1.44

FCF Yield+13.99%

Debt / Equity0.66

Interest Coverage1.2x

No credit card required

Already have an account? Sign in to view the full analysis for PCRX.